Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

被引：96
作者：
Tanasi, Ilaria [1 ,2 ]
Ba, Ibrahima [3 ,4 ]
Sirvent, Nicolas [5 ]
Braun, Thorsten [6 ]
Cuccuini, Wendy [3 ]
Ballerini, Paola [7 ]
Duployez, Nicolas [8 ]
Tanguy-Schmidt, Aline [9 ,10 ,11 ]
Tamburini, Jerome [12 ]
Maury, Sebastien [13 ]
Dore, Eric [14 ]
Himberlin, Chantal [15 ]
Duclos, Cedric [16 ]
Chevallier, Patrice [17 ]
Rousselot, Philippe [18 ]
Bonifacio, Massimiliano [2 ]
Cave, Helene [19 ]
Baruchel, Andre [20 ,21 ]
Dombret, Herve [1 ,21 ]
Soulier, Jean [3 ,4 ]
Landman-Parker, Judith [22 ]
Boissel, Nicolas [1 ,21 ]
Clappier, Emmanuelle [3 ,4 ]
机构：
[1] St Louis Hosp, AP HP, Hematol Dept, Paris, France
[2] Univ Verona, Sect Hematol, Dept Med, Verona, Italy
[3] St Louis Hosp, AP HP, Hematol Lab, Paris, France
[4] Univ Paris, CNRS, St Louis Res Inst, INSERM,U944,UMR 7212, Paris, France
[5] Montpellier Hosp, Pediat Oncohematol Dept, Montpellier, France
[6] Avicenne Hosp, AP HP, Hematol Dept, Paris, France
[7] Trousseau Hosp, AP HP, Hematol Lab, Paris, France
[8] Ctr Hosp Univ CHU Lille, Hematol Lab, Lille, France
[9] Angers Univ Hosp, Dept Hematol, Angers, France
[10] CRCINA, INSERM 1232, Nantes, France
[11] FHU GOAL, Angers, France
[12] Cochin Hosp, AP HP, Hematol Dept, Paris, France
[13] Henri Mondor Hosp, AP HP, Hematol Dept, Creteil, France
[14] Clermont Ferrand Univ Hosp, Dept Pediat, Clermont Ferrand, France
[15] Reims Univ Hosp, Dept Hematol, Reims, France
[16] Cote Basque Hosp, Dept Hematol, Bayonne, France
[17] Nantes Univ Hosp, Dept Hematol, Nantes, France
[18] Univ Paris Saclay, Versailles Andre Mignot Hosp, Dept Hematol, Le Chesnay, France
[19] Robert Debre Hosp, AP HP, Dept Genet, Paris, France
[20] Robert Debre Hosp, AP HP, Pediat Oncohematol Dept, Paris, France
[21] Univ Paris, St Louis Res Inst, EA 3518, Paris, France
[22] Sorbonne Univ, Trousseau Hosp, AP HP, Pediat Hematol Oncol Dept, Paris, France
来源：
BLOOD | 2019年 / 134卷 / 16期
关键词：
MINIMAL RESIDUAL DISEASE; MURINE XENOGRAFT MODELS; IMATINIB; ADULTS;
D O I：
10.1182/blood.2019001244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1351 / 1355
页数：5
相关论文
共 19 条
  • [1] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [2] Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
    Collette, Y.
    Prebet, T.
    Goubard, A.
    Adelaide, J.
    Castellano, R.
    Carbuccia, N.
    Garnier, S.
    Guille, A.
    Arnoulet, C.
    Charbonier, A.
    Mozziconacci, M. J.
    Birnbaum, D.
    Chaffanet, M.
    Vey, N.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e292 - e292
  • [3] A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
    Den Boer, Monique L.
    van Slegtenhorst, Marjon
    De Menezes, Renee X.
    Cheok, Meyling H.
    Buijs-Gladdines, Jessica G. C. A. M.
    Peters, Susan T. C. J. M.
    Van Zutven, Laura C. M.
    Beverloo, H. Berna
    Van der Spek, Peter J.
    Escherich, Gaby
    Horstmann, Martin A.
    Janka-Schoub, Gritta E.
    Kamps, Willem A.
    Evans, William E.
    Pieters, Rob
    [J]. LANCET ONCOLOGY, 2009, 10 (02) : 125 - 134
  • [4] NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors
    Duployez, Nicolas
    Grzych, Guillaume
    Ducourneau, Benoit
    Fuentes, Martin Alarcon
    Grardel, Nathalie
    Boyer, Thomas
    Abou Chahla, Wadih
    Bruno, Benedicte
    Nelken, Brigitte
    Clappier, Emmanuelle
    Preudhomme, Claude
    [J]. HAEMATOLOGICA, 2016, 101 (04)
  • [5] UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
    Fielding, Adele K.
    Rowe, Jacob M.
    Buck, Georgina
    Foroni, Letizia
    Gerrard, Gareth
    Litzow, Mark R.
    Lazarus, Hillard
    Luger, Selina M.
    Marks, David I.
    McMillan, Andrew K.
    Moorman, Anthony V.
    Patel, Bella
    Paietta, Elisabeth
    Tallman, Martin S.
    Goldstone, Anthony H.
    [J]. BLOOD, 2014, 123 (06) : 843 - 850
  • [6] Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia
    Frech, Miriam
    Jehn, Lutz B.
    Stabla, Kathleen
    Mielke, Stephan
    Steffen, Bjoern
    Einsele, Hermann
    Metzelder, Stephan K.
    Neubauer, Andreas
    [J]. HAEMATOLOGICA, 2017, 102 (04) : E160 - E162
  • [7] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    [J]. BLOOD, 2018, 131 (14) : 1522 - 1531
  • [8] Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
    Harvey, Richard C.
    Mullighan, Charles G.
    Wang, Xuefei
    Dobbin, Kevin K.
    Davidson, George S.
    Bedrick, Edward J.
    Chen, I-Ming
    Atlas, Susan R.
    Kang, Huining
    Ar, Kerem
    Wilson, Carla S.
    Wharton, Walker
    Murphy, Maurice
    Devidas, Meenakshi
    Carroll, Andrew J.
    Borowitz, Michael J.
    Bowman, W. Paul
    Downing, James R.
    Relling, Mary
    Yang, Jun
    Bhojwani, Deepa
    Carroll, William L.
    Camitta, Bruce
    Reaman, Gregory H.
    Smith, Malcolm
    Hunger, Stephen P.
    Willman, Cheryl L.
    [J]. BLOOD, 2010, 116 (23) : 4874 - 4884
  • [9] Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis
    Herold, Tobias
    Schneider, Stephanie
    Metzeler, Klaus H.
    Neumann, Martin
    Hartmann, Luise
    Roberts, Kathryn G.
    Konstandin, Nikola P.
    Greif, Philipp A.
    Braeundl, Kathrin
    Ksienzyk, Bianka
    Huk, Natalia
    Schneider, Irene
    Zellmeier, Evelyn
    Jurinovic, Vindi
    Mansmann, Ulrich
    Hiddemann, Wolfgang
    Mullighan, Charles G.
    Bohlander, Stefan K.
    Spiekermann, Karsten
    Hoelzer, Dieter
    Bruggemann, Monika
    Baldus, Claudia D.
    Dreyling, Martin
    Goekbuget, Nicola
    [J]. HAEMATOLOGICA, 2017, 102 (01) : 130 - 138
  • [10] Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
    Jain, Nitin
    Roberts, Kathryn G.
    Jabbour, Elias
    Patel, Keyur
    Eterovic, Agda Karina
    Chen, Ken
    Zweidler-McKay, Patrick
    Lu, Xinyan
    Fawcett, Gloria
    Wang, Sa A.
    Konoplev, Sergej
    Harvey, Richard C.
    Chen, I-Ming
    Payne-Turner, Debbie
    Valentine, Marcus
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Cortes, Jorge
    Kornblau, Steven
    O'Brien, Susan
    Pierce, Sherry
    Jorgensen, Jeffrey
    Shaw, Kenna R. Mills
    Willman, Cheryl L.
    Mullighan, Charles G.
    Kantarjian, Hagop
    Konopleva, Marina
    [J]. BLOOD, 2017, 129 (05) : 572 - 581
12